Spyros Papapetropoulos

Insider Reports History

Location
Emeryville, CA
Signature
/s/ Spyros Papapetropoulos
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Spyros Papapetropoulos:

Company Role Class Num Shares Value Price $ Report Date Ownership
Neuphoria Therapeutics Inc. President and CEO, Director Employee Stock Option (Right-to- Buy) 74,088 $612,707 $8.27 27 Aug 2025 Direct
Lipocine Inc. Director Stock Option (Right to Buy) 7,174 $22,956 $3.20 04 Jun 2025 Direct
Vigil Neuroscience, Inc. Chief Medical Officer Common Stock 4,000 $15,000 $3.75 18 Nov 2022 Direct
Vigil Neuroscience, Inc. Chief Medical Officer Stock Option Grant (Right to Buy) 149,604 18 Nov 2022 Direct
Adamas Pharmaceuticals Inc Director Common Stock 0 $5.16 24 Nov 2021 Direct
Adamas Pharmaceuticals Inc Director Stock Option (Right to Buy) 0 24 Nov 2021 Direct

Insider Reports Filed by Spyros Papapetropoulos

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NEUP Neuphoria Therapeutics Inc. 27 Aug 2025 1 +$285,803 4 President and CEO, Director 02 Sep 2025, 07:02
LPCN Lipocine Inc. 04 Jun 2025 1 +$5,645 4 Director 05 Jun 2025, 16:06
NEUP Neuphoria Therapeutics Inc. 16 Apr 2025 1 +$139,320 4/A President and CEO, Director 19 May 2025, 16:40
NEUP Neuphoria Therapeutics Inc. 16 Apr 2025 1 +$1,393,200 4 President and CEO, Director 18 Apr 2025, 08:04
NEUP BIONOMICS LIMITED/FI 01 Jul 2024 0 $0 3 Chief Executive Officer, Director 08 Jul 2024, 06:10
LPCN Lipocine Inc. 05 Jun 2024 1 +$12,436 4 Director 07 Jun 2024, 17:48
LPCN Lipocine Inc. 10 May 2023 1 +$7,968 4 Director 12 May 2023, 16:37
LPCN Lipocine Inc. 22 Nov 2022 1 +$10,217 4 Director 28 Nov 2022, 15:33
VIGL Vigil Neuroscience, Inc. 18 Nov 2022 3 -$3,633 4 Chief Medical Officer 22 Nov 2022, 20:45
LPCN Lipocine Inc. 08 Jun 2022 1 +$20,240 4 Director 10 Jun 2022, 11:34
VIGL Vigil Neuroscience, Inc. 03 May 2022 1 +$13,591 4 Chief Medical Officer 04 May 2022, 07:00
LPCN Lipocine Inc. 11 Apr 2022 1 +$11,600 4 Director 12 Apr 2022, 17:00
LPCN Lipocine Inc. 11 Apr 2022 0 $0 3 Director 12 Apr 2022, 16:58
VIGL Vigil Neuroscience, Inc. 01 Mar 2022 1 $0 4 Chief Medical Officer 03 Mar 2022, 15:05
VIGL Vigil Neuroscience, Inc. 06 Jan 2022 0 $0 3 Chief Medical Officer 06 Jan 2022, 19:31
/report/000132814321000089-papapetropoulos-spyridon-2021-11-24 Adamas Pharmaceuticals Inc 24 Nov 2021 3 $0 4 Director 24 Nov 2021, 15:09
/report/000132814321000060-papapetropoulos-spyridon-2021-06-02 Adamas Pharmaceuticals Inc 02 Jun 2021 2 $0 4 Director 04 Jun 2021, 16:16